Germanica

Germanica Pharmaceutical Industries (GPI) is a prominent Egyptian pharmaceutical company focused on the development, manufacturing, and distribution of high-quality branded generic medications. Established in 2008, the company has rapidly expanded its portfolio to cover a wide range of therapeutic areas, including cardiology, gastroenterology, neurology, and respiratory medicine. GPI operates a state-of-the-art manufacturing facility in the 6th of October City, designed to meet international Good Manufacturing Practice (GMP) standards and quality control protocols. The company's business model centers on providing cost-effective alternatives to innovator drugs, supporting healthcare accessibility in Egypt and the broader MENA region. With a strong emphasis on therapeutic efficacy and market expansion, Germanica continues to introduce new formulations and dosage forms to its growing product line.